Voluven
Generic name:hydroxyethyl starch 130/0.4
Dosage form: injection, solution
Drug class:Plasma expanders
Medically reviewed by Drugs.com. Last updated on Nov 22, 2021.
On This Page
- Boxed Warning
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
- In critically ill adult patients, including patients with sepsis, use of hydroxyethyl starch (HES) products, including Voluven ®, increases risk of
- Mortality
- Renal replacement therapy
- Do not use HES products, including Voluven ®, in critically ill adult patients, including patients with sepsis.
The Voluven brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Indications and Usage for Voluven
Voluven ® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) is indicated for the treatment and prophylaxis of hypovolemia in adults and children. It is not a substitute for red blood cells or coagulation factors in plasma.
Voluven Dosage and Administration
Voluven ® is administered by intravenous infusion only. The daily dose and rate of infusion depend on the patient’s blood loss, on the maintenance or restoration of hemodynamics and on the hemodilution (dilution effect). Voluven ® can be administered repetitively over several days. [see
